OneMedNet Corporation
NASDAQ Global MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Aaron Green
- Full Time Employees
- 23
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- 6385 Old Shady Oak Road Eden Prairie MN United States of America 55344
- IPO Date
- Jun 24, 2021
- CIK
- 0001849380
- Website
- onemednet.com
- Similar Companies
- Business
- OneMedNet Corporation OneMedNet Corporation (Nasdaq: ONMD), a healthcare software company, provides AI-powered real-world data (RWD) solutions, including digital medical image management, exchange, sharing, and de-identification platforms, primarily through its proprietary iRWD platform and BEAM medical imaging exchange system. The iRWD platform delivers regulatory-grade, de-identified imaging and clinical data, encompassing electronic health records, laboratory results, and longitudinal patient records across domains such as oncology, cardiology, rare diseases, and beyond; it supports pharmaceutical companies, medical device manufacturers, contract research organizations, AI developers, and academic researchers with secure, federated access to data from over 1,750 healthcare sites without transferring patient information from provider servers. BEAM facilitates imaging exchange among hospitals, healthcare systems, imaging centers, physicians, and patients, while recent expansions include AI-driven data masking services for de-identifying sensitive information in healthcare, finance, retail, and telecom sectors to enable compliant AI training and testing. Founded in 2006 and headquartered in Eden Prairie, Minnesota, the company operates in the Americas, Europe, and the Middle East, targeting life sciences, AI, and healthcare innovation markets with a workforce of approximately 23 employees. Its federated network model ensures data privacy and HIPAA compliance, positioning it in the competitive real-world evidence and health information services industry. Recent developments include a strategic partnership in August 2025 with one of the world's five largest medical device companies under a master services agreement for AI-powered RWD services, encompassing four purchase orders for medical imaging data; a collaboration with Palantir Technologies announced in October 2025 to advance AI-driven healthcare data integration and analytics; and an alliance with mlHealth360 in October 2025 to provide RWD for AI model development in healthcare. Additional 2025 initiatives encompass partnerships with Protege for real-time multimodal patient data access, Datavant’s real-world data ecosystem, Inka Health for cancer therapy trial external control arms, Medcase for healthcare data annotation market entry, and integrations with Amazon Data Exchange and Bayer Data Marketplace; the company expanded its cardiovascular data network by 85 centers, grew its clinical exam repository to over 121 million, and raised approximately $3.7 million through private placements. These moves enhance its subscription-based live data access model, annual recurring revenue, and capabilities in AI innovation and post-market surveillance.
Company News
OneMedNet Signs Global Pharmaceutical Intelligence Provider as Channel Partner, Extending Reach in Pharma Market
OneMedNet Adds Leading Hospital System Provider Network, Expanding By Up to 12 Hospitals
OneMedNet Signs Mediplexus as its 11th Channel Partner, Expanding the Company's Real World Data Footprint into Korea and the Asia Pacific Region
OneMedNet Signs Seven Figure Multiyear Agreement to Power a Partner Sold Derivative Data Solution
OneMedNet Corporation Announces 1-for-10 Reverse Stock Split
Atropos Health Scales Federated Evidence Network with Multimodal Data Partners to Accelerate Health Analytics and AI Model Development
OneMedNet Expands Commercial Reach Through Multi-Year Resale Agreement with Atropos Health
OneMedNet Reports Record Bookings as Faster Fulfillment Begins
OneMedNet (NASDAQ:ONMD) and Certara (NASDAQ:CERT) Financial Comparison
OneMedNet's iRWD Platform Enables Rapid Feasibility-to-Delivery for Leading AI-Driven Drug Development Company
OneMedNet (NASDAQ:ONMD) Director Acquires $999,999.75 in Stock
OneMedNet Secures $11.5+ Million Agreement to Supply Regulatory-Grade Real-World Data for Foundational AI Model Development
OneMedNet Executes on Growth Strategy: Secures Over $3 Million in New Bookings, Surpassing Full-Year 2025
OneMedNet Surpasses 90 Million Patient Journeys and 270 Million Studies within its Network
Insider Buying: OneMedNet (NASDAQ:ONMD) Director Acquires $249,999.22 in Stock
OneMedNet Goes Live with 80 Million Patient Journeys and Billions of Records
OneMedNet Announces Strong 2025 Financials and Advances AI-Driven iRWD™ powered by Palantir Foundry enabling Conversational Search on Real-Time Medical Data
OneMedNet, Onco-Innovations and Inka Health Announces Collaboration Aimed to Accelerate Potential for Oncology Drug Development Using Real-World Data and AI
OneMedNet and Navidence Announce Strategic Collaboration: Empowering Pharma with Precision Real-World Data Insights
What's Going On With Penny Stock OneMedNet On Tuesday?